Quelle est la différence entre le cannabis médical et le CBD bien-être ?

Le cannabis médical est un médicament contenant du THC et du CBD délivré exclusivement sur ordonnance médicale en pharmacie pour des pathologies précises. Le CBD bien-être contient moins de 0,3 % de THC, est disponible en vente libre et ne constitue pas un traitement médical.

Quelles sont les indications retenues par l'ANSM pour le cannabis médical ?

L'expérimentation cible cinq indications : les douleurs neuropathiques réfractaires, certaines épilepsies sévères, les symptômes oncologiques rebelles, les situations palliatives et la spasticité liée à la sclérose en plaques.

Peut-on acheter du cannabis médical dans un commerce de CBD classique ?

Non. Le cannabis médical est strictement réservé au circuit pharmaceutique et hospitalier sous ordonnance. Les boutiques de CBD commercialisent uniquement des produits de bien-être légaux à faible teneur en THC (< 0,3 %).

Medical Cannabis in France: Experimentation, ANSM and Prospects

Cannabis Médical en France : Expérimentation, ANSM et Perspectives

In recent years, the legal framework surrounding cannabis in France has undergone major changes. Initiated by the French National Agency for the Safety of Medicines and Health Products (ANSM), the medical cannabis experiment has made it possible to evaluate the integration of cannabinoid-based medicines into the care pathway of thousands of patients.

While this experimental phase paves the way for a permanent status and regulated generalization, it is essential to distinguish between prescription therapeutic cannabis and over-the-counter CBD for well-being.

1. Review of the Medical Cannabis Experiment in France

Officially launched in March 2021, the French experiment targeted five very specific medical indications for which conventional treatments were insufficient or ineffective:

Neuropathic pain refractory to usual therapies.
Certain forms of severe and drug-resistant epilepsies.
Rebellious symptoms in oncology and during anti-cancer treatments.
Complex palliative situations.
Painful spasticity associated with multiple sclerosis or other central nervous system disorders.

After the closure of new patient inclusions in spring 2024, a transitional period of continuity of care has been established until 2026. This step ensures the management of patients integrated into the system while finalizing the framework for authorization of access or market authorization (MA) for cannabis-based medicines.

2. Medical Cannabis vs. Wellness CBD: An Essential Distinction

There is sometimes confusion between medical cannabis dispensed in the context of hospital follow-up and cannabidiol (CBD) products available commercially.

Medical Cannabis (Medication): These are pharmaceutical preparations containing varying proportions of THC and CBD. These products are subject to strict medical prescription (secure prescription), dispensed exclusively in community pharmacies or for internal use (PUI), and reserved for diagnosed pathologies.
Wellness CBD (Plant Product): These are hemp flowers and extracts from authorized varieties, containing a THC level strictly below 0.3%. They are not medicines, do not require a prescription, and are used to support a daily calming or relaxation approach.

To learn more about the natural interaction of phytocannabinoids with our bodies, you can discover how the endocannabinoid system works.

3. The Role of Terpenes and the Entourage Effect in Research

The work carried out during the experiment highlighted the complexity of the hemp plant. In addition to THC and CBD, researchers are closely interested in secondary cannabinoids as well as volatile aromatic molecules.

In both the scientific and plant wellness fields, researchers emphasize the importance of the natural synergy between the components of the plant. Let's not hesitate to understand how the entourage effect works to grasp how these compounds act in harmony.

The distinction of botanical profiles also remains a key element in the choice of varieties. You can consult our guide on the difference between Sativa and Indica profiles to better understand these aromatic and plant nuances.

4. Regulation, Quality, and Precautions for Use

When it comes to well-being, access to traceable and natural products is an absolute priority.

Absence of therapeutic claims: Wellness CBD products must under no circumstances be presented as medical treatments or substitute for prescriptions from health professionals.
Quality of extracts: Prioritizing flowers and resins from controlled organic cultivation avoids exposure to chemical inputs. To ensure a healthy experience, it is advisable to avoid synthetic molecules.
Compliance of uses: In accordance with European directives (Novel Food), wellness flowers and resins are used by ambient vaporization or in skin care, without encouraging oral ingestion. For example, you can discover our organic CBD flowers or explore our French CBD resins.

In conclusion, the gradual generalization of medical cannabis will mark a significant advance for specialized medicine in France, while wellness CBD continues to offer a natural and regulated solution to support daily serenity.

Reminder: CBD is a wellness solution and is not a medicine. In case of illness or ongoing treatment, consult your doctor.

Back to blog

Our flowers

Canebiera réunit le meilleur du chanvre cultivé en Provence : fleurs, résines, huiles, infusions et soins naturels.
Chaque produit est pensé avec maîtrise, transparence et respect de la plante, pour offrir une expérience authentique et raffinée du chanvre, du terroir jusqu’à votre routine.